CIK 0001729427
- Non-accelerated filer
- Smaller reporting company
CNS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- CNSP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 822318545
- Phone
- +1 800-946-9185
- Business address
- 2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 33,333 shares at $0.30 ($10,000)
- 4 Open-market buy Director bought 33,333 shares at $0.30 ($10,000)
- 4 Open-market buy Chief Financial Officer bought 66,666 shares at $0.30 ($20,000)
- 4 Open-market buy Chief Executive Officer bought 166,666 shares at $0.30 ($50,000)
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 5 · 90 filings